citric acid, anhydrous has been researched along with Hyperuricemia in 4 studies
Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
Hyperuricemia: Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter (7.0mg/dL) in men or 0.36mmol per liter (6.0mg/dL) in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined (LESCH-NYHAN SYNDROME). It is associated with HYPERTENSION and GOUT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These results indicate that an additional use of citrate preparations with xanthine oxidase inhibitors is beneficial for patients with hyperuricemia, reducing circulating uric acid and improving their glomerular filtration rates." | 5.14 | The alkalizer citrate reduces serum uric Acid levels and improves renal function in hyperuricemic patients treated with the xanthine oxidase inhibitor allopurinol. ( Ito, H; Ito, Y; Kino, T; Matsuzawa, Y; Nishikawa, T; Omura, M; Saito, J; Yajima, Y; Yoshimura, K, 2010) |
| " In our study, calcium and uric acid abnormalities were the most common, and vesicoureteral reflux seemed to be the most common urological abnormality which led to urinary stasis and calculus formation." | 3.76 | Metabolic factors associated with urinary calculi in children. ( Alamdaran, SA; Naseri, M; Varasteh, AR, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naseri, M | 1 |
| Varasteh, AR | 1 |
| Alamdaran, SA | 1 |
| Saito, J | 1 |
| Matsuzawa, Y | 1 |
| Ito, H | 1 |
| Omura, M | 1 |
| Ito, Y | 1 |
| Yoshimura, K | 1 |
| Yajima, Y | 1 |
| Kino, T | 1 |
| Nishikawa, T | 1 |
| Honda, M | 1 |
| Yamamoto, K | 1 |
| Momohara, C | 1 |
| Komori, K | 1 |
| Takada, T | 1 |
| Fujioka, H | 1 |
| Pasch, A | 1 |
1 trial available for citric acid, anhydrous and Hyperuricemia
| Article | Year |
|---|---|
The alkalizer citrate reduces serum uric Acid levels and improves renal function in hyperuricemic patients treated with the xanthine oxidase inhibitor allopurinol.
Topics: Allopurinol; Citric Acid; Creatinine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; | 2010 |
3 other studies available for citric acid, anhydrous and Hyperuricemia
| Article | Year |
|---|---|
Metabolic factors associated with urinary calculi in children.
Topics: Adolescent; Calcium; Child; Child, Preschool; Citric Acid; Cystinuria; Female; Humans; Hypercalciuri | 2010 |
[Oral chemolysis of uric acid stones].
Topics: Administration, Oral; Allopurinol; Citric Acid; Combined Modality Therapy; Drug Therapy, Combination | 2003 |
[Metaphylaxis of recurrent renal calcium stones].
Topics: Calcium Oxalate; Calcium Phosphates; Citric Acid; Humans; Hypercalciuria; Hyperoxaluria; Hyperuricem | 2007 |